Effect of Radial Shock Wave Therapy on Spasticity of the Upper Limb in Patients With Chronic Stroke: A Prospective, Randomized, Single Blind, Controlled Trial

Tsung-Ying Li, Chih-Ya Chang, Yu-Ching Chou, Liang-Cheng Chen, Heng-Yi Chu, Shang-Lin Chiang, Shin-Tsu Chang, Yung-Tsan Wu, Tsung-Ying Li, Chih-Ya Chang, Yu-Ching Chou, Liang-Cheng Chen, Heng-Yi Chu, Shang-Lin Chiang, Shin-Tsu Chang, Yung-Tsan Wu

Abstract

Recently, studies have reported that extracorporeal shock wave therapy (ESWT) is a safe, noninvasive, alternative treatment for spasticity. However, the effect of ESWT on spasticity cannot be determined, because most studies to date have enrolled small patient numbers and have lacked placebo-controlled groups and/or long-term follow-up. In addition, whether varying the number of ESWT sessions would affect the duration of the therapeutic effect has not been investigated in a single study. Hence, we performed a prospective, randomized, single blind, placebo-controlled study to investigate the long-term effect of radial ESWT (rESWT) in patients with poststroke spasticity and surveyed the outcome of functional activity.Sixty patients were randomized into 3 groups. Group A patients received 1 session of rESWT per week for 3 consecutive weeks; group B patients received a single session of rESWT; group C patients received one session of sham rESWT per week for 3 consecutive weeks. The primary outcome was Modified Ashworth Scale of hand and wrist, whereas the secondary outcomes were Fugl-Meyer Assessment of hand function and wrist control. Evaluations were performed before the first rESWT treatment and immediately 1, 4, 8, 12, and 16 weeks after the last session of rESWT.Compared to the control group, the significant reduction in spasticity of hand and wrist lasted at least 16 and 8 weeks in group A and B, respectively. Three sessions of rESWT had a longer-lasting effect than one session. Furthermore, the reduction in spasticity after 3 sessions of rESWT may be beneficial for hand function and wrist control and the effect was maintained for 16 and 12 weeks, respectively.rESWT may be valuable in decreasing spasticity of the hand and wrist with accompanying enhancement of wrist control and hand function in chronic stroke patients.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Timeline of treatment session with data collection in 3 groups. Group A patients received 1 session of radial extracorporeal shock wave therapy (rESWT) per week for 3 consecutive weeks; group B patients received a single session of rESWT; group C patients received 1 session of sham rESWT per week for 3 consecutive weeks. Evaluations were performed before the 1st rESWT treatment and immediately 1, 4, 8, 12, and 16 weeks after the last session of rESWT in each group (except hand function and wrist control immediately after rESWT).
FIGURE 2
FIGURE 2
CONSORT flow diagram.
FIGURE 3
FIGURE 3
Mean of change from baseline in MAS in all groups (mean ± standard error). (A) MAS of hand: group B had significant improvement compared with group C until week 12. The differences between group A and group B reach significant at most of the observed time-points (except week 1 and week 4). (B) MAS of wrist: group B had significant improvement compared with group C until week 8. The differences between group A and group B reach significant at most of the observed time-points (except week 1). (∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 mean group A vs B; +P < 0.05, ++P < 0.01, and +++P < 0.001 mean group B vs C. One-way ANOVA followed by the Bonferroni post hoc tests was used). ANOVA = analysis of variance, MAS = Modified Ashworth Scale.
FIGURE 4
FIGURE 4
Mean of change from baseline in FMA in all groups (mean ± standard error). (A) FMA of hand function: group A had significant improvement compared with group B and C at all observed time-points. (B) FMA of wrist control: the difference in group A was significantly larger than those of group C until week 8 and those of group B until week 12. (∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 mean group A vs B; +++P < 0.001 mean group A vs C. One-way ANOVA followed by the Bonferroni post hoc tests was used). ANOVA = analysis of variance, FAS = Fugl-Meyer Assessment.

References

    1. Gerdesmeyer L, Wagenpfeil S, Haake M, et al. Extracorporeal shock wave therapy for the treatment of chronic calcifying tendonitis of the rotator cuff: a randomized controlled trial. JAMA 2003; 290:2573–2580.
    1. Chang KV, Chen SY, Chen WS, et al. Comparative effectiveness of focused shock wave therapy of different intensity levels and radial shock wave therapy for treating plantar fasciitis: a systematic review and network meta-analysis. Arch Phys Med Rehabil 2012; 93:1259–1268.
    1. Watkins CL, Leathley MJ, Gregson JM, et al. Prevalence of spasticity post stroke. Clin Rehabil 2002; 16:515–522.
    1. Duncan PW, Zorowitz R, Bates B, et al. Management of Adult Stroke Rehabilitation Care: a clinical practice guideline. Stroke 2005; 36:100–143.
    1. Francisco GE, McGuire JR. Poststroke spasticity management. Stroke 2012; 43:3132–3136.
    1. Manganotti P, Amelio E. Long-term effect of shock wave therapy on upper limb hypertonia in patients affected by stroke. Stroke 2005; 36:1967–1971.
    1. Bae H, Lee JM, Lee KH. The effects of extracorporeal shock wave therapy on spasticity in chronic stroke patients. J Korean Acad Rehabil Med 2010; 34:663–669.
    1. Yoo SD, Kim HS, Jung PK. The effect of shock wave therapy on upper limb spasticityin the patients with stroke. J Korean Acad Rehabil Med 2008; 32:406–410.
    1. Sohn MK, Cho KH, Kim YJ, et al. Spasticity and electrophysiologic changes after extracorporeal shock wave therapy on gastrocnemius. Ann Rehabil Med 2011; 35:599–604.
    1. Moon SW, Kim JH, Jung MJ, et al. The effect of extracorporeal shock wave therapy on lower limb spasticity in subacute stroke patients. Ann Rehabil Med 2013; 37:461–470.
    1. Santamato A, Notarnicola A, Panza F, et al. SBOTE study: extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type a injection for post-stroke spasticity-a prospective randomized trial. Ultrasound Med Biol 2013; 39:283–291.
    1. Troncati F, Paci M, Myftari T, et al. Extracorporeal Shock Wave Therapy reduces upper limb spasticity and improves motricity in patients with chronic hemiplegia: a case series. NeuroRehabilitation 2013; 33:399–405.
    1. Santamato A, Micello MF, Panza F, et al. Extracorporeal shock wave therapy for the treatment of poststroke plantar-flexor muscles spasticity: a prospective open-label study. Top Stroke Rehabil 2014; 21:S17–S24.
    1. Kim YW, Shin JC, Yoon JG, et al. Usefulness of radial extracorporeal shock wave therapy for the spasticity of the subscapularis in patients with stroke: a pilot study. Chin Med J (Engl) 2013; 126:4638–4643.
    1. Daliri SS, Forogh B, Emami Razavi SZ, et al. A single blind, clinical trial to investigate the effects of a single session extracorporeal shock wave therapy on wrist flexor spasticity after stroke. NeuroRehabilitation 2015; 36:67–72.
    1. Amelio E, Manganotti P. Effect of shock wave stimulation on hypertonic plantar flexor muscles in patients with cerebral palsy: a placebo-controlled study. J Rehabil Med 2010; 42:339–343.
    1. Vidal X, Morral A, Costa L, et al. Radial extracorporeal shock wave therapy (rESWT) in the treatment of spasticity in cerebral palsy: a randomized, placebo-controlled clinical trial. NeuroRehabilitation 2011; 29:413–419.
    1. Gonkova MI, Ilieva EM, Ferriero G, et al. Effect of radial shock wave therapy on muscle spasticity in children with cerebral palsy. Int J Rehabil Res 2013; 36:284–290.
    1. El-Shamy SM, Eid MA, El-Banna MF. Effect of extracorporeal shock wave therapy on gait pattern in hemiplegic cerebral palsy: a randomized controlled trial. Am J Phys Med Rehabil 2014; 93:1065–1072.
    1. Marinelli L, Mori L, Solaro C, et al. Effect of radial shock wave therapy on pain and muscle hypertonia: a double-blind study in patients with multiple sclerosis. Mult Scler 2014; 21:622–629.
    1. Lee JY, Kim SN, Lee IS, et al. Effects of Extracorporeal Shock Wave Therapy on Spasticity in Patients after Brain Injury: a meta-analysis. J Phys Ther Sci 2014; 26:1641–1647.
    1. Wade DT, Wood VA, Hewer RL. Recovery after stroke – the first 3 months. J Neurol Neurosurg Psychiatry 1985; 48:7–13.
    1. Cacchio A, Paoloni M, Barile A, et al. Effectiveness of radial shock-wave therapy for calcific tendinitis of the shoulder: single-blind, randomized clinical study. Phys Ther 2006; 86:672–682.
    1. Lin FM, Sabbahi M. Correlation of spasticity with hyperactive stretch reflexes and motor dysfunction in hemiplegia. Arch Phys Med Rehabil 1999; 80:526–530.
    1. Fugl-Meyer AR, Jaasko L, Leyman I, et al. The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med 1975; 7:13–31.
    1. Duncan PW, Propst M, Nelson SG. Reliability of the Fugl-Meyer assessment of sensorimotor recovery following cerebrovascular accident. Phys Ther 1983; 63:1606–1610.
    1. Faul F, Erdfelder E, Lang AG, et al. G∗Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39:175–191.
    1. Mariotto S, Cavalieri E, Amelio E, et al. Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide 2005; 12:89–96.
    1. Leone JA, Kukulka CG. Effects of tendon pressure on alpha motoneuron excitability in patients with stroke. Phys Ther 1988; 68:475–480.
    1. Mariotto S, de Prati AC, Cavalieri E, et al. Extracorporeal shock wave therapy in inflammatory diseases: molecular mechanism that triggers anti-inflammatory action. Curr Med Chem 2009; 16:2366–2372.
    1. Kenmoku T, Ochiai N, Ohtori S, et al. Degeneration and recovery of the neuromuscular junction after application of extracorporeal shock wave therapy. J Orthop Res 2012; 30:1660–1665.
    1. Galiana L, Fung J, Kearney R. Identification of intrinsic and reflex ankle stiffness components in stroke patients. Exp Brain Res 2005; 165:422–434.
    1. Sinkjaer T, Toft E, Larsen K, et al. Non-reflex and reflex mediated ankle joint stiffness in multiple sclerosis patients with spasticity. Muscle Nerve 1993; 16:69–76.
    1. Lagalla G, Danni M, Reiter F, et al. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. Am J Phys Med Rehabil 2000; 79:377–384.
    1. Simpson DM, Alexander DN, O’Brien CF, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996; 46:1306–1310.
    1. Bakheit AM, Pittock S, Moore AP, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 2001; 8:559–565.
    1. Alter KE. High-frequency ultrasound guidance for neurotoxin injections. Phys Med Rehabil Clin N Am 2010; 21:607–630.

Source: PubMed

3
Se inscrever